ELISA Kit for Gremlin 1 (GREM1)

Ruiz-Carpio V, Sandoval P, Aguilera A, et al. Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients. Sci Rep. 2017,7:44941. doi: 10.1038/srep44941

Tekari A, May RD, Frauchiger DA, et al. The BMP2 variant L51P restores the osteogenic differentiation of human mesenchymal stromal cells in the presence of intervertebral disc cells. Eur Cell Mater. 2017,33:197-210. doi: 10.22203/eCM.v033a15

Hu K, Sun H, Gui B, et al. Gremlin-1 suppression increases BMP-2-induced osteogenesis of human mesenchymal stem cells. Mol Med Rep. 2017,15(4):2186-2194. doi: 10.3892/mmr.2017.6253

Chatterjee M, Behrendt A, Schmid M, et al. Platelets as a novel source of Gremlin-1: Implications for thromboinflammation. Thromb Haemost. 2017,117(2):311-324. doi: 10.1160/TH16-08-0665

Barnes JW, Kucera ET, Tian L, et al. Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension. Am J Respir Cell Mol Biol. 2016,55(4):564-575.

Han EJ, Yoo SA, Kim GM, et al. GREM1 Is a Key Regulator of Synoviocyte Hyperplasia and Invasiveness. J Rheumatol. 2016,43(3):474-85. doi: 10.3899/jrheum.150523

Behnes M, Bertsch T, Weiss C, et al. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients. Int J Cardiol. 2016,203:398-406. doi: 10.1016/j.ijcard.2015.10.127

Yin Y, Yang Y, Yang L, et al. Overexpression of Gremlin promotes non-small cell lung cancer progression. Tumour Biol. 2016,37(2):2597-602. doi: 10.1007/s13277-015-4093-8

Wellbrock J, Harbaum L, Stamm H, et al. Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension. Lung. 2015,193(4):567-70. doi: 10.1007/s00408-015-9735-5